ALLIENT INC 10-Qquarter ended 2026-06-30

PositiveRestructuring

Industrial and Aerospace and Defense demand lifts margins; rising receivables, inventory and capex squeeze cash.

Filed 2026-08-05 16:11 ET

Key figures · Q2 FY2026 · period ended 2026-06-30

  • Revenue$153.8MYoY +10.2%
  • Operating income$15.6MYoY +33.7%
  • Net income— Unavailable
  • Total assets$593.9M
  • Total debt$173.3M
  • Shareholders' equity$312.3MYoY +8.0%
  • Tangible book value$97.7M

How this filing reads

  • Health+0.3Cash was $42.1M against $173M debt, while H1 free cash flow remained positive at $13.1M.
  • Momentum+0.7Q2 revenue rose 10% and operating income 34%, with gross margin expanding 1.7 points.
  • Outlook+0.5Bookings rose 49% and backlog reached $298M, supporting prospective demand amid execution and cash-conversion risks.
  • Restructuring“The Simplify to Accelerate NOW program is moving Dothan assembly operations to Tulsa and Reynosa while developing Dothan into a Fabrication Center of Excellence.”

Executive Summary

Allient’s Q2 acceleration was primarily volume-driven, with Industrial demand and Aerospace and Defense strength supporting higher sales and better manufacturing economics. Revenue grew 10%, while operating income rose 34%; lower interest expense and taxes further amplified earnings growth. Bookings substantially exceeded shipments, creating a growth opportunity, but rising receivables, inventory and capital spending reduced cash available after investment. The investment thesis is that stronger demand and manufacturing consolidation can sustain margin gains while converting the expanding backlog into cash—not merely additional working capital.

Key Financial Highlights

Metric Q2 2026 H1 2026 / 6/30/2026 balance Investor interpretation
Revenue $154M; +10% Y/Y $293M; +7.5% Y/Y Volume drove most quarterly growth
Gross profit $53.6M; +16% Y/Y $99.0M; +11% Y/Y Mix and operational improvements added leverage
Gross margin 34.9%, from 33.2% 33.8%, from 32.7% Gains extended beyond sales growth
GAAP operating income $15.6M; +34% Y/Y $24.9M; +22% Y/Y Higher overhead partly absorbed gross-profit gains
GAAP net income / diluted EPS $10.4M / $0.61; income +85% Y/Y $15.7M / $0.93; income +72% Y/Y Financing and tax benefits amplified operating improvement
EBITDA, non-GAAP $21.7M; +26% Y/Y $37.3M; +18% Y/Y Growth lagged GAAP net-income growth
OCF / FCF — $20.1M / $13.1M; down 48% / 63% Y/Y Working capital and investment consumed more cash
Total assets — $594M; +2.8% since year-end Working-capital expansion increased the asset base
Total equity — $312M; +3.6% since year-end Earnings strengthened book capital
Tangible common equity — $97.7M Goodwill and intangibles represent much of book equity
Cash / long-term debt — $42.1M / $173M; debt down 3.9% since year-end Deleveraging continued despite lower cash generation
Target market Q2 revenue Y/Y change
Industrial $76M +17%
Vehicle $25M −6.6%
Medical $22M +8.9%
Aerospace and Defense $24M +16%
Distribution and Other $6.3M −1.7%
  • Cash conversion: H1 OCF exceeded net income, but receivables absorbed $12.2M and inventory $11.3M; a $14.4M accounts-payable contribution partly offset those uses. Capital expenditures increased to $7.07M from $3.19M.
  • Earnings quality: Q2 interest expense fell 29% to $2.52M, while the effective tax rate declined to 20.2% from 23.1%; these benefits explain part of earnings growth beyond operating gains. Management expects a ≈21%–23% full-year tax rate.
  • Balance-sheet composition: Goodwill of $133M and other net intangible assets of $81.5M explain the gap between total and tangible equity; the goodwill decline reflected currency translation, not impairment.

Business Developments

Allient is expanding its Motion, Controls and Power capabilities through internal investment and acquisitions. Current growth was concentrated in Industrial and Aerospace and Defense, while Vehicle remained a drag, demonstrating that demand recovery is uneven across its markets.

Q2 bookings increased 49% to $201M, exceeding revenue by $47.5M; backlog reached $298M, up 26% Y/Y. This strengthens prospective production demand, although orders must still convert into shipments.

The Simplify to Accelerate NOW program is moving Dothan assembly operations to Tulsa and Reynosa while developing Dothan into a Fabrication Center of Excellence. Management expects annualized savings in 2026; H1 restructuring and realignment costs were $1.50M. Planned full-year capital expenditures of $12M–$15M support continued operational investment.

Risk Assessment

  • Backlog conversion and cash absorption: Rapid order growth creates delivery opportunities, but additional inventory and slower collections could prevent revenue growth from translating into comparable cash generation.
  • Manufacturing transition: Assembly transfers and fabrication consolidation introduce execution risk; disruption could offset expected savings through delayed shipments or additional transition costs.
  • Trade-policy uncertainty: Tariffs and geopolitical developments could affect input costs, supply availability and customer ordering; potential refunds sought following the 2026 tariff ruling had neither been approved nor received.
  • Hedge expiry: A $40M interest-rate swap expires in 12/2026, potentially increasing floating-rate exposure unless replaced or matched by debt reduction.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: the company's 10-Ks on SEC.

Strategic Outlook and Investor Actionables

Management is betting that stronger Industrial demand, Aerospace and Defense growth and manufacturing simplification will sustain operating improvement. The opportunity is to convert a larger order book through a more efficient footprint; the threat is that transition costs and working-capital requirements absorb the benefits.

  • Industrial recovery: Q2 revenue rose 17%. Subsequent filings should show whether demand sustains growth or whether the rebound fades.
  • Aerospace and Defense expansion: Q2 revenue increased 16%. Continued growth would validate this demand pillar; declining shipments despite the larger company backlog would weaken it.
  • Manufacturing simplification: H1 restructuring costs were $1.50M. The program works if gross-margin gains persist as transition costs recede; disruption or recurring charges would undermine the savings case.
  • Cash conversion: H1 FCF declined to $13.1M despite higher earnings. Improving collections and inventory conversion alongside debt reduction would validate growth quality; continued cash absorption would challenge it.

Figures are computed from the filing's XBRL data; the summary and scores are written by an AI model reading the filing.

Model 006 · prompt 41c4ca4692 · 2026-10-15 18:32:16Z

Feedback